http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1628971-B1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1542e8802a0e6a7a8a7c6bd5627eb857 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4196 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-14 |
filingDate | 2004-05-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2008-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6af2e89a26a56580ef090d9a14b387f5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0031772e3bbffec98cd80baa9cbc45c5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7b49a705c09d17167b89f3e868af7892 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1faa49e5bc5c404c27329e6594dd957f |
publicationDate | 2008-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | EP-1628971-B1 |
titleOfInvention | TRIAZOLE-DERIVATIVES AS FACTOR Xa INHIBITORS |
abstract | The present invention relates to compounds of the formulae I and II, <CHEM> <CHEM> in which R<0>; R<1>; R<2>; R<3>; Q; J<1>; J<2>; J<3>; J<4>; J<5>; V; G and M have the meanings indicated in the claims. The compounds of the formulae I and II are valuable pharmacologically active compounds. They exhibit a strong antithrombotic effect and are suitable, for example, for the therapy and prophylaxis of cardiovascular disorders like thromboembolic diseases or restenoses. They are reversible inhibitors of the blood clotting enzymes factor Xa (FXa) and/or factor VIIa (FVIIa), and can in general be applied in conditions in which an undesired activity of factor Xa and/or factor VIIa is present or for the cure or prevention of which an inhibition of factor Xa and/or factor VIIa is intended. The invention furthermore relates to processes for the preparation of compounds of the formulae I and II, their use, in particular as active ingredients in pharmaceuticals, and pharmaceutical preparations comprising them. |
priorityDate | 2003-05-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 156.